LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Pfizer Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$3.54M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-16.54%
quarter
Pfizer Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.03% | -22 shares | -703K | $43.76 | 81.02K |
| Q2 2022 | share | Increase | +2.15% | 1.70K shares | 142K | $52.43 | 81.04K |
| Q1 2022 | share | Decrease | -0.47% | -377 shares | -600K | $51.77 | 79.33K |
| Q4 2021 | share | 0.00% | 0 shares | 1.27M | $58.4 | 79.71K | |
| Q3 2021 | share | Decrease | -1.26% | -1.01K shares | 268K | $42.63 | 79.71K |
| Q2 2021 | share | Increase | +4.95% | 3.80K shares | 374K | $38.46 | 80.73K |
| Q1 2021 | share | Increase | +11.21% | 7.75K shares | 241K | $35.24 | 76.92K |
| Q4 2020 | share | Increase | +5.22% | 3.43K shares | 257K | $35.41 | 69.16K |
| Q3 2020 | share | Decrease | -8.77% | -6.32K shares | 54K | $33.15 | 65.73K |
| Q2 2020 | share | Decrease | -0.93% | -678 shares | -17K | $29.25 | 72.05K |
| Q1 2020 | share | Decrease | -2.94% | -2.20K shares | -534K | $28.9 | 72.73K |
| Q4 2019 | share | Decrease | -4.66% | -3.66K shares | 107K | $34.34 | 74.93K |
| Q3 2019 | share | Decrease | -0.93% | -741 shares | -582K | $31.19 | 78.59K |
| Q2 2019 | share | Increase | +30.90% | 18.72K shares | 819K | $37.25 | 79.33K |
| Q1 2019 | share | Decrease | -10.62% | -7.19K shares | -366K | $36.2 | 60.61K |
| Q4 2018 | share | Increase | +6.57% | 4.18K shares | 148K | $36.89 | 67.80K |
| Q3 2018 | share | Decrease | -1.43% | -926 shares | 438K | $36.96 | 63.62K |
| Q2 2018 | share | Decrease | -4.87% | -3.30K shares | -63K | $30.17 | 64.55K |
| Q1 2018 | share | Decrease | -8.85% | -6.58K shares | -273K | $29.23 | 67.85K |
| Q4 2017 | share | Increase | +0.63% | 465 shares | 52K | $29.56 | 74.44K |
| Q3 2017 | share | Decrease | -0.10% | -75 shares | 176K | $28.87 | 73.98K |
| Q2 2017 | share | Decrease | -14.72% | -12.78K shares | -489K | $26.9 | 74.05K |
| Q1 2017 | share | Decrease | -0.10% | -84 shares | 140K | $27.14 | 86.84K |
| Q4 2016 | share | Increase | +4.71% | 3.90K shares | 11K | $25.51 | 86.92K |
| Q3 2016 | share | Decrease | -0.12% | -97 shares | -109K | $26.33 | 83.01K |
| Q2 2016 | share | Increase | +15.86% | 11.38K shares | 760K | $27.15 | 83.11K |
| Q1 2016 | share | Decrease | -15.79% | -13.45K shares | -592K | $22.65 | 71.73K |